Alcarelle and Alcarelle-based products are planned to be available in the US from 2028. Alcarelle will be licensed to the Drinks Industry so they can develop a new generation of functional alcohol alternative products for adult social drinkers.
Sentia Spirits uses GABA Labs’ botanical extracts to develop and market functional award-winning adult beverages, available today at Sentia Spirits.
“Alcarelle” is a functional biomimetic ingredient (ie a synthetic compound that replicates the behaviour of a natural substance), and is odourless, tasteless and colourless. It will be used by Drinks Cos to develop a new generation of adult beverages. They will determine taste, texture and colours as the consumer market demands.
“Sentia” is the first in a range of functional botanical products. Since launching in 2021, Sentia has sold 200,000 units so far, and has received many industry awards. Future botanical products are in the pipeline.
Before Alcarelle can be released to market it must comply with strict regulatory testing protocols defined by the respective food regulatory authority.
The objective of the testing and regulatory work is to ensure that we create a safe, functional and socially beneficial product.
GABA Labs’ mission is to create ingredients that are non-addictive and better than alcohol. Demonstrating safety is a crucial part of the regulatory safety testing process.
We are heartened by the number of people offering to support us by participating in this process. However, this won’t be possible. The testing will be managed by an independent third party whose testing protocols:
- don’t permit the contracting organisation (in this case GABA Labs) to put forward any volunteers
- require testers to be recruited via channels that ensure independence, objectivity and suitability in terms of profile for the specific testing cohort
Please go to our Investors’ page for further information.
GABA Labs is not hiring right now.
If you have another question for us, ask it here.